Machine Learning Expands Across Endocrinology - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Machine Learning Expands Across Endocrinology

Machine learning "might provide remarkable benefits to the endocrine field."

  • By

  • Doug Brunk

  • March 4, 2026

  • 4 min

Share

Clinical Scorecard: Machine Learning Expands Across Endocrinology

At a Glance

CategoryDetail
ConditionEndocrine Disorders
Key MechanismsMachine Learning applications in imaging, risk prediction, and treatment-response modeling.
Target PopulationPatients with non-diabetic endocrine disorders.
Care SettingClinical settings involving endocrinology departments.

Key Highlights

  • 1,130 studies identified, with 68% focused on thyroid diseases.
  • ML models show high diagnostic performance in thyroid nodule evaluation.
  • Deep learning reduced unnecessary biopsies by 27% while maintaining accuracy.
  • ML applications in adrenal disorders achieved AUC values above 0.94.
  • Limitations include lack of model transparency and small sample sizes.

Guideline-Based Recommendations

Diagnosis

  • Use ML models for imaging-based evaluations and risk stratification.

Management

  • Integrate ML findings into clinical decision-making with specialist supervision.

Monitoring & Follow-up

  • Employ ML for predicting postoperative outcomes and complications.

Risks

  • Address data imbalance and the need for external validation of ML models.

Patient & Prescribing Data

Individuals with thyroid, pituitary, adrenal, and parathyroid disorders.

ML can enhance diagnostic accuracy and reduce unnecessary interventions.

Clinical Best Practices

  • Encourage interdisciplinary collaboration between healthcare professionals and data scientists.
  • Focus on high-quality, well-designed ML research in endocrinology.
  • Standardize reporting and validation processes for ML models.

Related Resources & Content

Original Source(s)

Machine Learning Expands Across Endocrinology

  • by Doug Brunk

  • March 4, 2026

Related Content

Do Revisions in Rotator Cuff Repair Decline With GLP-1 Use?

Preoperative use was associated with fewer revisions and no increase in short-term complications among patients with obesity, although benefits appeared concentrated in select subgroups.

Pregnancy Health Score Tied to Later Cardiometabolic Risk

A modified cardiovascular health score during pregnancy was associated with later diagnosis of chronic hypertensive and metabolic conditions.

ACP Ranks Obesity Drug Options

A living clinical guideline outlines a treatment hierarchy for selected pharmacologic therapies in patients with obesity and selected patients with overweight.